Literature DB >> 22184405

IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing.

Francesca Spadaro1, Caterina Lapenta, Simona Donati, Laura Abalsamo, Vincenzo Barnaba, Filippo Belardelli, Stefano M Santini, Maria Ferrantini.   

Abstract

Cross-presentation allows antigen-presenting cells to present exogenous antigens to CD8(+) T cells, playing an essential role in controlling infections and tumor development. IFN-α induces the rapid differentiation of human mono-cytes into dendritic cells, known as IFN-DCs, highly efficient in mediating cross-presentation, as well as the cross-priming of CD8(+) T cells. Here, we have investigated the mechanisms underlying the cross-presentation ability of IFN-DCs by studying the intracellular sorting of soluble ovalbumin and nonstructural-3 protein of hepatitis C virus. Our results demonstrate that, independently from the route and mechanism of antigen entry, IFN-DCs are extraordinarily competent in preserving internalized proteins from early degradation and in routing antigens toward the MHC class-I processing pathway, allowing long-lasting, cross-priming capacity. In IFN-DCs, both early and recycling endosomes function as key compartments for the storage of both antigens and MHC-class I molecules and for proteasome- and transporter-associated with Ag processing-dependent auxiliary cross-presentation pathways. Because IFN-DCs closely resemble human DCs naturally occurring in vivo in response to infections and other danger signals, these findings may have important implications for the design of vaccination strategies in neoplastic or chronic infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22184405     DOI: 10.1182/blood-2011-06-363564

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  61 in total

1.  Differential use of autophagy by primary dendritic cells specialized in cross-presentation.

Authors:  Justine D Mintern; Christophe Macri; Wei Jin Chin; Scott E Panozza; Elodie Segura; Natalie L Patterson; Peter Zeller; Dorothee Bourges; Sammy Bedoui; Paul J McMillan; Adi Idris; Cameron J Nowell; Andrew Brown; Kristen J Radford; Angus Pr Johnston; Jose A Villadangos
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 2.  Regulation of antiviral T cell responses by type I interferons.

Authors:  Josh Crouse; Ulrich Kalinke; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2015-03-20       Impact factor: 53.106

3.  Dynamic analysis of immune and cancer cell interactions at single cell level in microfluidic droplets.

Authors:  S Sarkar; P Sabhachandani; D Stroopinsky; K Palmer; N Cohen; J Rosenblatt; D Avigan; T Konry
Journal:  Biomicrofluidics       Date:  2016-10-12       Impact factor: 2.800

4.  Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunity.

Authors:  Yi Zhang; Guo Chen; Zuqiang Liu; Shenghe Tian; Jiying Zhang; Cara D Carey; Kenneth M Murphy; Walter J Storkus; Louis D Falo; Zhaoyang You
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

5.  Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy.

Authors:  B Montico; C Lapenta; M Ravo; D Martorelli; E Muraro; B Zeng; E Comaro; M Spada; S Donati; S M Santini; R Tarallo; G Giurato; F Rizzo; A Weisz; F Belardelli; R Dolcetti; J Dal Col
Journal:  Oncoimmunology       Date:  2017-07-31       Impact factor: 8.110

6.  Phenotypic and functional profile of IFN-α-differentiated dendritic cells (IFN-DCs) from HIV-infected individuals.

Authors:  Bruna Tereso Santillo; Denise da Silva Reis; Laís Teodoro da Silva; Nathalia Teixeira Romani; Alberto José da Silva Duarte; Telma Miyuki Oshiro
Journal:  Hum Vaccin Immunother       Date:  2018-12-20       Impact factor: 3.452

7.  Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

Authors:  Stefan Nierkens; Jurjen Tel; Edith Janssen; Gosse J Adema
Journal:  Trends Immunol       Date:  2013-03-27       Impact factor: 16.687

8.  Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells.

Authors:  Geoffrey L Rogers; Jamie L Shirley; Irene Zolotukhin; Sandeep R P Kumar; Alexandra Sherman; George Q Perrin; Brad E Hoffman; Arun Srivastava; Etiena Basner-Tschakarjan; Mark A Wallet; Cox Terhorst; Moanaro Biswas; Roland W Herzog
Journal:  Blood       Date:  2017-05-03       Impact factor: 22.113

9.  A catalytically inactive mutant of the deubiquitylase YOD-1 enhances antigen cross-presentation.

Authors:  Sharvan Sehrawat; Paul-Albert Koenig; Oktay Kirak; Christian Schlieker; Manuel Fankhauser; Hidde L Ploegh
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

Review 10.  Fueling autoimmunity: type I interferon in autoimmune diseases.

Authors:  Jeremy Di Domizio; Wei Cao
Journal:  Expert Rev Clin Immunol       Date:  2013-03       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.